Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.

Savaryn JP, Reitsma JM, Bigley TM, Halligan BD, Qian Z, Yu D, Terhune SS.

J Virol. 2013 Mar;87(5):2463-74. doi: 10.1128/JVI.01926-12. Epub 2012 Dec 12.

2.

Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.

Terhune SS, Moorman NJ, Cristea IM, Savaryn JP, Cuevas-Bennett C, Rout MP, Chait BT, Shenk T.

PLoS Pathog. 2010 Jun 24;6(6):e1000965. doi: 10.1371/journal.ppat.1000965.

3.

Human Cytomegalovirus Protein pUL38 Prevents Premature Cell Death by Binding to Ubiquitin-Specific Protease 24 and Regulating Iron Metabolism.

Sun Y, Bao Q, Xuan B, Xu W, Pan D, Li Q, Qian Z.

J Virol. 2018 Jun 13;92(13). pii: e00191-18. doi: 10.1128/JVI.00191-18. Print 2018 Jul 1.

PMID:
29695420
4.

Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.

Bai Y, Xuan B, Liu H, Zhong J, Yu D, Qian Z.

J Virol. 2015 Aug;89(15):7625-35. doi: 10.1128/JVI.01027-15. Epub 2015 May 13.

5.

Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Castillo JP, Frame FM, Rogoff HA, Pickering MT, Yurochko AD, Kowalik TF.

J Virol. 2005 Sep;79(17):11467-75.

6.

Inhibition of p53 transcriptional activity by human cytomegalovirus UL44.

Kwon Y, Kim MN, Young Choi E, Heon Kim J, Hwang ES, Cha CY.

Microbiol Immunol. 2012 May;56(5):324-31. doi: 10.1111/j.1348-0421.2012.00446.x.

7.

Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Hwang ES, Zhang Z, Cai H, Huang DY, Huong SM, Cha CY, Huang ES.

J Virol. 2009 Dec;83(23):12388-98. doi: 10.1128/JVI.00304-09. Epub 2009 Sep 23.

8.

Biphasic regulation of A20 gene expression during human cytomegalovirus infection.

Gu SY, Kim YE, Kwon KM, Han TH, Ahn JH.

Virol J. 2014 Jul 8;11:124. doi: 10.1186/1743-422X-11-124.

9.

Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Zydek M, Hagemeier C, Wiebusch L.

PLoS Pathog. 2010 Sep 9;6(9):e1001096. doi: 10.1371/journal.ppat.1001096.

10.
12.

Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.

Reichel A, Stilp AC, Scherer M, Reuter N, Lukassen S, Kasmapour B, Schreiner S, Cicin-Sain L, Winterpacht A, Stamminger T.

J Virol. 2018 Jun 29;92(14). pii: e00342-18. doi: 10.1128/JVI.00342-18. Print 2018 Jul 15.

PMID:
29743358
13.

Functional interaction of the human cytomegalovirus IE2 protein with histone deacetylase 2 in infected human fibroblasts.

Park JJ, Kim YE, Pham HT, Kim ET, Chung YH, Ahn JH.

J Gen Virol. 2007 Dec;88(Pt 12):3214-23.

PMID:
18024889
14.

HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

Hsu CH, Chang MD, Tai KY, Yang YT, Wang PS, Chen CJ, Wang YH, Lee SC, Wu CW, Juan LJ.

EMBO J. 2004 Jun 2;23(11):2269-80. Epub 2004 May 13.

15.
16.

Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.

Choi WI, Yoon JH, Kim MY, Koh DI, Licht JD, Kim K, Hur MW.

J Biol Chem. 2014 Jul 4;289(27):18641-56. doi: 10.1074/jbc.M113.538777. Epub 2014 May 12.

17.

The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.

Muganda P, Carrasco R, Qian Q.

Cell Mol Biol (Noisy-le-grand). 1998 Mar;44(2):321-31.

PMID:
9593583
18.

Human cytomegalovirus UL38 protein blocks apoptosis.

Terhune S, Torigoi E, Moorman N, Silva M, Qian Z, Shenk T, Yu D.

J Virol. 2007 Apr;81(7):3109-23. Epub 2007 Jan 3.

20.

Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence.

Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, Gariglio M, Landolfo S.

J Virol. 2002 Dec;76(23):12135-48.

Supplemental Content

Support Center